Hidemi Hayashi

1.5k total citations
29 papers, 1.2k citations indexed

About

Hidemi Hayashi is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Hidemi Hayashi has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Oncology and 6 papers in Pharmacology. Recurrent topics in Hidemi Hayashi's work include Microbial Natural Products and Biosynthesis (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Hidemi Hayashi is often cited by papers focused on Microbial Natural Products and Biosynthesis (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Hidemi Hayashi collaborates with scholars based in Japan, United States and Greece. Hidemi Hayashi's co-authors include Shin‐ichiro Niwa, Toshihiko Kishimoto, Keiji Tanaka, Shigeo Murata, Yousuke Takahama, Katsuhiro Sasaki, Hideyuki Saya, Yoshimi Arima, Yoichi Taya and Tatsuhiro Shibata and has published in prestigious journals such as Science, Journal of Biological Chemistry and Molecular Cell.

In The Last Decade

Hidemi Hayashi

27 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hidemi Hayashi Japan 14 801 424 234 222 185 29 1.2k
Parul Hazarika United States 12 960 1.2× 336 0.8× 347 1.5× 159 0.7× 158 0.9× 16 1.5k
Kirill V. Rosen Canada 19 875 1.1× 330 0.8× 130 0.6× 192 0.9× 227 1.2× 37 1.2k
Emily Chu United States 7 1.3k 1.7× 627 1.5× 319 1.4× 225 1.0× 123 0.7× 14 1.7k
Isao Matsuura United States 20 1.2k 1.5× 513 1.2× 164 0.7× 194 0.9× 59 0.3× 40 1.5k
Robert Kubiak Poland 18 553 0.7× 206 0.5× 144 0.6× 121 0.5× 154 0.8× 77 1.1k
Jean Charles Dagorn France 21 601 0.8× 388 0.9× 143 0.6× 121 0.5× 111 0.6× 27 1.1k
Csaba Mahotka Germany 22 1.4k 1.7× 517 1.2× 350 1.5× 126 0.6× 159 0.9× 46 1.7k
Catherine J. Huntoon United States 22 857 1.1× 536 1.3× 386 1.6× 135 0.6× 77 0.4× 30 1.4k
Jennifer Mariano United States 20 1.1k 1.4× 418 1.0× 123 0.5× 324 1.5× 234 1.3× 32 1.5k
Cynthia Kosinski United States 9 695 0.9× 427 1.0× 99 0.4× 123 0.6× 71 0.4× 9 1.2k

Countries citing papers authored by Hidemi Hayashi

Since Specialization
Citations

This map shows the geographic impact of Hidemi Hayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidemi Hayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidemi Hayashi more than expected).

Fields of papers citing papers by Hidemi Hayashi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidemi Hayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidemi Hayashi. The network helps show where Hidemi Hayashi may publish in the future.

Co-authorship network of co-authors of Hidemi Hayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Hidemi Hayashi. A scholar is included among the top collaborators of Hidemi Hayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidemi Hayashi. Hidemi Hayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hayashi, Hidemi, Koji Sawada, Hiroki Tanaka, et al.. (2023). The effect of heat‐killed Lactobacillus brevis SBL88 on improving selective hepatic insulin resistance in non‐alcoholic fatty liver disease mice without altering the gut microbiota. Journal of Gastroenterology and Hepatology. 38(10). 1847–1854. 6 indexed citations
3.
Aso, Kazunobu, Hidemi Hayashi, Shunsuke Nakajima, et al.. (2023). Contrast-enhanced Ultrasonography Features for Diagnosing Pseudoprogression of Hepatocellular Carcinoma with Immunotherapy: A Case Report of the Response after Pseudoprogression. Internal Medicine. 63(8). 1093–1097. 1 indexed citations
4.
Sawada, Koji, Yuji Nishikawa, Hidemi Hayashi, et al.. (2019). Successful Treatment of Nivolumab-related Cholangitis with Prednisolone: A Case Report and Review of the Literature. Internal Medicine. 58(12). 1747–1752. 25 indexed citations
6.
Sawada, Koji, Hidemi Hayashi, Shunsuke Nakajima, et al.. (2019). Long-term growth of intrahepatic papillary neoplasms: A case report. World Journal of Gastroenterology. 25(36). 5569–5577. 6 indexed citations
7.
Arima, Yoshimi, Hidemi Hayashi, Mikako Sasaki, et al.. (2012). Induction of ZEB Proteins by Inactivation of RB Protein Is Key Determinant of Mesenchymal Phenotype of Breast Cancer. Journal of Biological Chemistry. 287(11). 7896–7906. 64 indexed citations
8.
Arima, Yoshimi, Naoki Hayashi, Hidemi Hayashi, et al.. (2011). Loss of p16 expression is associated with the stem cell characteristics of surface markers and therapeutic resistance in estrogen receptor‐negative breast cancer. International Journal of Cancer. 130(11). 2568–2579. 59 indexed citations
9.
Arima, Yoshimi, Hidemi Hayashi, Takaaki Goto, et al.. (2009). Decreased expression of neurofibromin contributes to epithelial–mesenchymal transition in neurofibromatosis type 1. Experimental Dermatology. 19(8). e136–41. 42 indexed citations
10.
Arima, Yoshimi, Yasumichi Inoue, Tatsuhiro Shibata, et al.. (2008). Rb Depletion Results in Deregulation of E-Cadherin and Induction of Cellular Phenotypic Changes that Are Characteristic of the Epithelial-to-Mesenchymal Transition. Cancer Research. 68(13). 5104–5112. 131 indexed citations
11.
Yashiroda, Hideki, Tsunehiro Mizushima, Kenta Okamoto, et al.. (2008). Crystal structure of a chaperone complex that contributes to the assembly of yeast 20S proteasomes. Nature Structural & Molecular Biology. 15(3). 228–236. 96 indexed citations
12.
Murata, Shigeo, Katsuhiro Sasaki, Toshihiko Kishimoto, et al.. (2007). Regulation of CD8 + T Cell Development by Thymus-Specific Proteasomes. Science. 316(5829). 1349–1353. 456 indexed citations
13.
Hirano, Yuko, Hidemi Hayashi, Shun‐ichiro Iemura, et al.. (2006). Cooperation of Multiple Chaperones Required for the Assembly of Mammalian 20S Proteasomes. Molecular Cell. 24(6). 977–984. 122 indexed citations
14.
Igarashi, Masayuki, et al.. (2001). Some Biological and Biochemical Activities of Resormycin, a Novel Herbicidal Antibiotic.. The Journal of Antibiotics. 54(12). 1072–1079. 2 indexed citations
15.
T, Oka, et al.. (1997). Cloning of the Enomycin Structural Gene from Streptomyces mauvecolor and Production of Recombinant Enomycin in Escherichia coli.. The Journal of Antibiotics. 50(1). 27–31. 1 indexed citations
16.
Sakata, Nobuo, Hidemi Hayashi, Makoto Hori, et al.. (1992). Aminopeptidase activity of an antitumor antibiotic, C-1027.. The Journal of Antibiotics. 45(1). 113–117. 9 indexed citations
17.
Sakata, Nobuo, et al.. (1989). NUCLEOTIDE SEQUENCE OF THE MACROMOMYCIN APOPROTEIN GENE AND ITS EXPRESSION IN STREPTOMYCES MACROMOMYCETICUS. The Journal of Antibiotics. 42(11). 1704–1713. 11 indexed citations
18.
Hayashi, Hidemi, et al.. (1980). Biosynthesis of leupeptin. III. Isolation and properties of an enzyme synthesizing acetyl-L-leucine.. The Journal of Antibiotics. 33(8). 857–862. 9 indexed citations
19.
Hayashi, Hidemi, et al.. (1979). Biosynthesis of leupeptin. II. Purification and properties of leupeptin acid synthetase.. The Journal of Antibiotics. 32(5). 523–530. 10 indexed citations
20.
Hori, Makoto, Hiromichi Hemmi, Hidemi Hayashi, et al.. (1978). Biosynthesis of leupeptin.. The Journal of Antibiotics. 31(1). 95–98. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026